Artificial Intelligence Ai Ophthalmology Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

AI in ophthalmology refers to software platforms that use deep learning and image recognition to detect, classify, and monitor eye conditions from retinal scans, OCT images, and visual-field data. The market is valued at around USD 420 million in 2025 and is projected to grow at roughly 33% annually, with forecasts placing it in the multi-billion-dollar range by the early 2030s. Adoption is concentrated in screening programmes for diabetic retinopathy, glaucoma assessment, AMD monitoring, and AI-assisted surgical planning.

• •2025 market value approximately USD 0.42 billion with a ~33% compound annual growth rate
• •Core applications include retinal disease screening, glaucoma detection, AMD monitoring, and surgical guidance
• •Most widely deployed technology is deep learning applied to fundus photography and OCT imaging

Rising global prevalence of diabetes and age-related eye disease is creating demand for scalable screening tools that can extend specialist expertise. At the same time, the volume of digitised retinal and OCT images is growing rapidly, providing the training data needed for accurate algorithms. Regulatory clearances from the US FDA and the European CE mark, along with reimbursement pathways in major markets, are accelerating real-world clinical adoption.

• •Growing burden of diabetic retinopathy, glaucoma, and AMD increases screening demand
• •Expansion of tele-ophthalmology and primary-care screening programmes creates new deployment channels
• •Increasing FDA and CE clearances are legitimising clinical use of ophthalmic AI

The market is segmented by application (disease detection and monitoring, surgical planning and outcome prediction), technology (deep learning and neural networks, natural language processing), deployment mode (cloud-based and on-premise), and end user (hospitals, specialty clinics, imaging centres, and screening programmes). North America currently leads due to regulatory approvals, reimbursement coverage, and concentration of vendors, while Asia-Pacific is the fastest-growing region because of large diabetic populations, government screening initiatives, and expanding digital health infrastructure.

• •Disease detection and monitoring is the largest application segment
• •Deep learning and neural networks dominate the technology mix
• •North America leads in revenue; Asia-Pacific is the fastest-growing regional market

What are the recent trends and outlook?

Future growth will be shaped by multimodal AI models that combine imaging with clinical and genomic data, expansion of autonomous screening in primary care and pharmacies, and deeper integration with electronic health records and ophthalmic surgical platforms. Reimbursement expansion in the US, EU, and Asia, combined with generative AI tools for clinical documentation, is expected to broaden use cases and push the market toward the multi-billion-dollar range over the next decade.

• •Multimodal AI combining imaging, clinical notes, and biomarkers is an emerging direction
• •Autonomous screening is extending into primary care, retail clinics, and tele-ophthalmology
• •Generative AI for clinical documentation and surgical planning is expanding the addressable market